Low levels of HGF and pMet in the tumour cell cytoplasm and high levels of pAkt in the tumour cell nucleus are associated with a larger benefit from RT, indicating that these proteins may be used as biomarkers or treatment targets. This evidence concerns the gene HGF and neoplasm.